JERUSALEM, Jan 17 (Reuters) - A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it likely is not enough to prevent Omicron infections, according to a preliminary study in Israel.
The vaccines led to a increase in the number of antibodies "even a little bit higher than what we had after the third dose", said Regev-Yochay, adding that the results were preliminary and not yet published.
Israel was the fastest country to roll out initial vaccinations a year ago and last month started offering a fourth shot, or a second booster, to the most vulnerable, high-risk groups. (Reporting by Ari Rabinovitch Editing by Mark Heinrich)
Our Standards: The Thomson Reuters Trust Principles.
